Taylor Ben R forfeited 5,396 RECURSION PHARMACEUTICALS shares at $3.41 per share. The transaction left the chief financial officer with 1,071,462 shares and represented about 0.5% of his prior holding, giving investors the disclosed size of the ownership change relative to his position.
Key Highlights
- The transaction occurred on September 15, 2026.
- The transaction used code F, which denotes tax-related withholding.
- Taylor Ben R held 1,071,462 shares after the transaction.
RECURSION PHARMACEUTICALS, INC. (NASDAQ: RXRX) recorded a forfeiture of 5,396 shares involving Chief Financial Officer Taylor Ben R at $3.41 per share. The transaction’s stated size was about 0.5% of Taylor Ben R’s prior share holding.
September 15 Share Forfeiture
The reported ownership figure after the transaction was 1,071,462 shares. The forfeiture represented about 0.5% of Taylor Ben R’s prior share holding. That percentage is measured against the officer’s position before the transaction, while the disclosed ownership figure applies afterward.
FAQs
Q: How many RECURSION PHARMACEUTICALS shares did Taylor Ben R forfeit?
A: Taylor Ben R forfeited 5,396 RECURSION PHARMACEUTICALS shares at $3.41 per share. He was identified as the company’s Chief Financial Officer.
Q: What was the size of Taylor Ben R’s share transaction relative to his holdings?
A: The forfeiture represented about 0.5% of Taylor Ben R’s prior share holding. His reported ownership after the transaction was 1,071,462 shares.
Q: What does code F mean in Taylor Ben R’s transaction?
A: The transaction occurred on September 15, 2026, and involved Taylor Ben R’s company shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.